Effect of BMP7 on podocyte transdifferentiation and Smad7 expression induced by hyperglycemia

Clinical Nephrology

Volumn 84, Issue 2, 2015, Pages 95-99

  Liu, Liqiu ^a   Fu, Wen ^a   Xu, Jing ^a   Shao, Leping ^a   Wang, Yanfei ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Bone morphogenetic proteins 7; Diabetic nephropathy; Podocytes; Smad7

Indexed keywords

DESMIN; GLUCOSE; MANNITOL; MESSENGER RNA; OSTEOGENIC PROTEIN 1; SMAD7 PROTEIN; SYNAPTOPODIN; ACTIN BINDING PROTEIN; BMP7 PROTEIN, MOUSE; SMAD7 PROTEIN, MOUSE; SYNPO PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; HYPERGLYCEMIA; IN VITRO STUDY; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE TECHNIQUE; CELL LINE; COMPARATIVE STUDY; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; PATHOPHYSIOLOGY; TIME FACTOR;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CELL CULTURE TECHNIQUES; CELL LINE; CELL TRANSDIFFERENTIATION; DESMIN; EPITHELIAL-MESENCHYMAL TRANSITION; GLUCOSE; HYPERGLYCEMIA; MANNITOL; MICE; MICROFILAMENT PROTEINS; PODOCYTES; SMAD7 PROTEIN; TIME FACTORS;

EID: 84941203544     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108569     Document Type: Article

References (19)

1. Susztak K, Raff AC, Schiffer M, Böttinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006; 55: 225-233. CrossRef PubMed
2. Nicolás FJ, Lehmann K, Warne PH, Hill CS, Downward J. Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest. J Biol Chem. 2003; 278: 3251-3256. CrossRef PubMed
3. Wang S, Hirschberg R. BMP7 antagonizes TGF-ß-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol. 2003; 284: F1006-F1013. CrossRef PubMed
4. Dalla Vestra M, Masiero A, Roiter AM, et al. Is Podocyte iniury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003; 52: 103l-1035. PubMEd
5. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood). 2008; 233: 4-11. CrossRef PubMed
6. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010; 21: 212-222. CrossRef PubMed
7. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008; 172: 299-308. Cross-Ref PubMed
8. De Petris L, Hruska KA, Chiechio S, Liapis H. Bone morphogenetic protein-7 delays podocyte injury due to high glucose. [J]. Nephrol Dial Transplant. 2007; 22: 3442-3450. CrossRef PubMed
9. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIVassociated nephropathy. Kidney Int. 2000; 58: 173-181. CrossRef PubMed
10. Kuhlmann A, Haas CS, Gross ML, Reulbach U, Holzinger M, Schwarz U, Ritz E, Amann K. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol. 2004; 286: F526-F533. CrossRef PubMed
11. Zou J, Yaoita E, Watanabe Y, Yoshida Y, Nameta M, Li H, Qu Z, Yamamoto T. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch. 2006; 448: 485-492. CrossRef PubMed
12. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003; 9: 964-968. CrossRef PubMed
13. Mitu GM, Wang S, Hirschberg R. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol. 2007; 293: F1641-F1648. CrossRef PubMed
14. Manson SR, Niederhoff RA, Hruska KA, Austin PF. The BMP-7-Smad1/5/8 pathway promotes kidney repair after obstruction induced renal injury. J Urol. 2011; 185 (Suppl): 2523-2530. CrossRef PubMed
15. Lan HY. Smad7 as a therapeutic agent for chronic kidney diseases. Front Biosci. 2008; 13: 4984-4992. CrossRef PubMed
16. Chen HY, Huang XR, Wang W, Li JH, Heuchel RL, Chung AC, Lan HY. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes. 2011; 60: 590-601. CrossRef PubMed
17. Huili Sun, Liao Sun, Jing Nie, et al. The effection of Smad7 on the epithelial cell transformation and collagen I combination of kidney tubules in rats induced by glucose. Chinese Journal of Kidney disease. 2006; 22: 539-544.
18. Jin Li, Ningning Wang, Ruoyin Tan, et al. Smad signal transduction pathways regulate the epithelial cell transformation of kidney tubules. J Nephrol Dialy Transplant. 2005; 14: 230-234.
19. Fuchshofer R, Stephan DA, Russell P, Tamm ER. Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-ß2 signaling. Exp Eye Res. 2009; 88: 1020-1032. CrossRef PubMed